APX3330 reverses the immunosuppressive tumor microenvironment during colorectal carcinogenesis

Key Points

• APX3330 effectively reverses the immunosuppressive tumor microenvironment during colorectal carcinogenesis.
• Key metrics indicate changes in cytokines and immune signaling pathways following treatment.
• The approach involved an analysis of cellular responses within the tumor microenvironment.
• Supports the notion that targeting immune pathways may enhance treatment outcomes in colorectal cancer.